Dr. Agarwal's Health Care IPO Day 2: Dr. Agarwal's Health Care shares get subscribed 0.42x times on day 2!Dr. Agarwal's Health Care IPO Day 2: Dr. Agarwal's Health Care shares get subscribed 0.42x times on day 2!

Dr. Agarwal’s Health Care IPO saw a total subscription of 0.42 times on Day 2. Qualified Institutional Buyers (QIBs) subscribed 1.01 times, while Non-Institutional Investors (NIIs) and Retail Investors subscribed 0.12 times and 0.23 times, respectively. Employee and shareholder categories recorded 0.17 times and 0.25 times subscriptions.

Dr. Agarwal’s Health Care Ltd IPO Subscription Status

Dr. Agarwal’s Health Care IPO saw a muted response on Day 1, with an overall subscription of 0.07x. The retail segment subscribed 0.11x, while NII and employees subscribed 0.06x and 0.08x, respectively. Shareholders showed higher interest with a 0.14x subscription, while QIBs remained at 0.00 times.

How to check Dr. Agarwal’s Health Care Ltd IPO Subscription Status?

Steps to check Dr. Agarwal’s Health Care Ltd IPO subscription status on NSE

Following are the steps to check it through the NSE website

• Visit NSE‘s official website.
• Navigate to the ‘Market Data’ tab.
• Choose ‘IPO’.
• Select the ‘Dr. Agarwal’s Health Care Ltd IPO’ to check its subscription status.
• Opt for either NSE Bid details or Consolidated Bid details.
• Explore the total number of bids received from various investors. 

Dr. Agarwal’s Health Care  Ltd IPO Allotment Status

The allotment date for the Dr. Agarwal’s Health Care Ltd IPO is set for February 3, with shares priced from ₹382 to ₹402 per share and a face value of ₹1. The offering consists of lots of 35 shares, with bids accepted for these lots or their multiples.

Dr. Agarwal’s Health Care Ltd IPO Listing Date 

Dr. Agarwal’s Health Care Ltd IPO is expected to be listed on the NSE SME on February 5, 2025.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.